Babylat is a revolutionary brand that has developed the first automated tabletop device for human milk protein enrichment. This innovative device solves the problem of a lack of macro- and micronutrients in the diet of preterm infants during their crucial first months of life. Babylat's device enriches the macronutrient content of human milk on-site, ensuring that preterm neonates receive the necessary nutrients without the use of non-human origin proteins.

The Babylat device is easy to use, requiring no special medical training or additional laboratory equipment. It automates all enrichment processes, making it accessible to all. By adding the enriched protein fraction to human milk, the device significantly increases its protein value without the need for cow milk products. This allows for the preparation of fortified human milk using only mother's milk or donor milk, aligning with the WHO's recommendation of a 100% human milk-based diet for infants during their first six months of life.

Babylat offers several benefits. It provides a time-efficient enrichment process, taking less time than other market-available solutions. The device uses only human milk with no chemical additives, ensuring the baby's health and minimizing risks. It also allows for product variability, enabling the selection of a unique composition to meet the individual needs of each baby. With on-site enrichment, hospitals can provide personalized nutrition to preterm neonates, enhancing their growth and development.

Another advantage of Babylat is its low cost. The device streamlines the production of fortified human milk, reducing production costs. Additionally, Babylat's novel fast protocol keeps the human milk-origin product as natural as possible, with less negative impact on CO2 emissions.

Importantly, Babylat maintains an ethical approach. The brand does not commercialize human milk and its derivatives. The origin of the human milk is strictly controlled by health providers, ensuring the highest standards of safety and ethics.

Founded in 2020 in Bern, Switzerland, Babylat is supported by various grants and awards, including one from Innosuisse, the leading national agency for innovation. The company is grateful for the support received from its sponsors and supporters as it continues to develop its solution into a market-ready product.

If you share the vision that every preterm neonate deserves a 100% human milk-based diet, Babylat welcomes your involvement. Join their mission in solving the problem of preterm nutrition. The team behind Babylat is comprised of highly dedicated individuals, including Zina Yudina, PhD, the Founder and CEO. Zina is a renowned protein biochemist and molecular biologist with extensive experience in research institutes worldwide. Ross Graham, CFO, brings over 20 years of experience in accounting and financial markets to the team.

For more information about Babylat's achievements and collaborations, please refer to the provided links. If you have any questions or would like to get in touch, Babylat can be reached via email or at their address in Bern, Switzerland. Stay connected with Babylat on LinkedIn for the latest updates.

Babylat is committed to revolutionizing preterm nutrition and invites you to be part of their journey towards improving the lives of preterm neonates through innovative solutions.